The Conversation: Who can’t have a COVID vaccine and how do I get a medical exemption?
State and territory governments and businesses are currently in the process of establishing COVID-19 vaccine mandates across a range of sectors, including the Victorian government which mandated COVID vaccination for all authorised workers last week. Despite this necessary step, there is still a very small amount of people who are unable to receive a COVID-19 vaccine for medical reasons. ATAGI has released guidelines on which instances an individual may be granted a medical exception.
The only criteria for a permanent exception are due to anaphylaxis following a previous COVID-19 vaccine dose or to any component of a vaccine.
Temporary exceptions may be approved for some “acute major medical illnesses” where the COVID vaccine can be deferred for a certain amount of time.
COVID vaccine exceptions can be administered by general practitioners, paediatricians, clinical immunologists, infectious disease, general or public health physicians, gynaecologists, or obstetricians. As vaccine mandates continue to be implemented, it’s crucial for employers, individuals, and medical providers to stay up to date with new ATAGI clinical guidance regarding the medical exemption criteria.
Click the link to read the full article:
The Conversation: Who can’t have a COVID vaccine and how do I get a medical exemption?
आयु: फाइजर और मॉडर्ना कोविड टीके अब 60 वर्ष से अधिक आयु के सभी ऑस्ट्रेलियाई लोगों के लिए उपलब्ध हैं
स्वास्थ्य मंत्री ग्रेग हंट ने घोषणा की है कि शुक्रवार, 1 अक्टूबर से 60 और उससे अधिक आयु के ऑस्ट्रेलियाई फाइजर और मॉडर्न प्राप्त करने में सक्षम होंगे, भले ही वे कहीं भी रहते हों, 300,000 से अधिक वृद्ध लोगों के लिए वैक्सीन विकल्प का विस्तार करना, जो टीका लगवाने की प्रतीक्षा कर रहे हैं।
इसके अलावा, यह भी घोषणा की गई है कि विक्टोरिया को 60 वर्ष से कम उम्र के लोगों पर ध्यान केंद्रित करने के लिए राज्य के क्लीनिकों में सहायता के लिए अतिरिक्त 88,900 मॉडर्ना खुराक प्राप्त होगी, जबकि जीपी और फार्मेसियां उन 60 और उससे अधिक के टीकाकरण पर ध्यान केंद्रित करेंगी।
लेख को पूरा पढ़ने के लिए कृपया नीचे दिए गए लिंक पर क्लिक करें:
आयु: फाइजर और मॉडर्ना कोविड टीके अब 60 वर्ष से अधिक आयु के सभी ऑस्ट्रेलियाई लोगों के लिए उपलब्ध हैं
Victorian Government COVID-19 Vaccination Enhancement Grants
The Victorian Government is offering COVID-19 Vaccination Enhancement Grants to pharmacies and general practices interested in maximising their capacity to deliver vaccines across identified geographic areas at higher risk of COVID-19.
The grants are designed to support primary care providers to utilise their full vaccine allocations and to confidently promote access in their local communities as well as fund additional workforce or operational costs associated with maximising COVID-19 vaccine administration.
To find out more information about the grants available, please click on the link below.
Victorian Government COVID-19 Vaccination Enhancement Grants
मॉडर्न फार्मेसी अपॉइंटमेंट ऑनलाइन बुकिंग प्लेटफॉर्म के माध्यम से उपलब्ध है
जैसे ही सामुदायिक फ़ार्मेसी देश भर में मॉडर्न वैक्सीन का प्रबंध करना शुरू करती हैं, नीचे सूचीबद्ध दो बुकिंग प्लेटफ़ॉर्म हैं जो आपकी निकटतम सामुदायिक फ़ार्मेसी का पता लगाने और वैक्सीन नियुक्ति के लिए उनकी उपलब्धता में सहायता कर सकते हैं।
एमवीईसी साइटों से संबद्ध नहीं हैं और जानकारी को केवल एक गाइड के रूप में इस्तेमाल किया जाना चाहिए।
आप नीचे दिए गए लिंक के माध्यम से बुकिंग प्लेटफॉर्म देख सकते हैं।
एक फार्मेसी खोजें
Covid19नियरमी
Healthed lecture series featuring Associate Professor Nigel Crawford
MVEC’s Associate Professor Nigel Crawford delivered the COVID-19 Update as part of the recent Healthed Australia online lecture series.
In this lecture, A/Prof Nigel Crawford discussed the following:
- An update on the latest ATAGI announcements
- Moderna safety data
- The booster debate
- Back to school
To listen to the lecture in full, click on the link below:
Healthed lecture series 28 September: COVID-19 Update
ATAGI statement about the need for additional doses of COVID-19 vaccines
The Australian Technical Advisory Group on Immunisation (ATAGI) has released a statement about the need for additional doses of COVID-19 vaccines.
The statement strongly recommends maximising first and second dose vaccine uptake across the community without delay in line with current prioritisation and outbreak response strategies and that two doses of any of the vaccines available in Australia have been shown to protect an individual from COVID-19 and its complications, as well as protecting the community.
ATAGI continues to closely monitor local and international data about the frequency and severity of COVID-19 in fully vaccinated individuals as well as reviewing the international data on the efficacy, effectiveness and safety of additional doses for specific high-risk patient populations, including immunocompromised individuals, and the population more generally. These data will inform future strategies regarding additional vaccine doses.
Additional doses can be defined as:
- Third doses: Additional COVID-19 doses required as part of the primary course to reach a comparable (optimal) level of protection
- Booster dose: Additional COVID-19 doses required at a broader population level, to optimise protection due to waning of immunity (loss of protection) over time, with booster doses also leading to improved immune memory.
To read the statement in full, please click the link below:
ATAGI statement about the need for additional doses of COVID-19 vaccines
Webinar recording now available: The Alfred community information session on COVID-19 vaccines
A webinar recording is now available from The Alfred’s community information session on COVID-19 vaccines which was held on Tuesday 21 September.
In this session, Allen Cheng and Associate Professor Nigel Crawford discuss in detail the COVID-19 vaccines, including the safety and efficacy in children over 12 years old, as well as answer questions from the community.
The full recording is available on The Alfred channels or the MVEC Facebook page via the links below:
The Alfred community discussion 21 September
MVEC Facebook page
ABC News: पांच से 11 साल के बच्चों के लिए इस्तेमाल होने वाली COVID-19 वैक्सीन के लिए मंजूरी के लिए आवेदन करेगी फाइजर
5 से 11 वर्ष की आयु के बच्चों के लिए Pfizer और BioNTech COVID-19 वैक्सीन की प्रभावशीलता और सुरक्षा का अध्ययन करने वाले 2,000 से अधिक बच्चों को शामिल करने वाले उच्च प्रत्याशित परीक्षण के शुरुआती परिणामों ने दिखाया है कि टीका सुरक्षित है और वायरस के खिलाफ एक मजबूत एंटीबॉडी प्रतिक्रिया स्थापित करता है।
प्रारंभिक आशाजनक परिणामों के बावजूद, यह अमेरिका और यहां ऑस्ट्रेलिया में 5 से 11 वर्ष की आयु के बच्चों के लिए टीकों के आधिकारिक रोलआउट से कुछ समय पहले होगा। एक बार परीक्षण का विश्लेषण पूरा हो जाने के बाद, अनुमोदन प्रदान करने के लिए, कंपनी को एफडीए को एक औपचारिक प्रतिरक्षा "ब्रिजिंग" अध्ययन प्रदान करने की आवश्यकता होती है, जो डेटा-आधारित साक्ष्य प्रदान करता है कि बच्चों ने वही एंटीबॉडी स्तर विकसित किए हैं जो पहले से ही सुरक्षात्मक साबित हुए हैं। बड़े बच्चों और किशोरों में। समीक्षा और आपातकालीन उपयोग प्राधिकरण के लिए परिणाम खाद्य एवं औषधि प्रशासन (एफडीए) को प्रस्तुत किए जाएंगे।
लेख को पूरा पढ़ने के लिए कृपया नीचे दिए गए लिंक पर क्लिक करें:
https://www.abc.net.au/news/2021-09-21/pfizer-covid-19-vaccine-5-to-11-year-old/100478362
ABC News: Israel is struggling with COVID-19, despite high vaccination rates. What lessons can Australia learn?
Due to an early and rapid vaccine roll-out, Israel was leading the way for COVID-19 immunisation, with nearly 80 per cent of its citizens aged 12 and over fully inoculated by June. However, cases numbers and rates of hospitalisations began to rapidly rise again by late June with Israel recording its highest single-day spike with 16,011 new infections on September 1.
As Australia works its way towards reopening, this article discusses the important lessons we can learn from Israel's vaccination program. Professor Lewin, Director of The Doherty Institute commented "What we've learned from [Israel], and what's consistent with the modelling is that even at 80 per cent, you need to have some public health measures in place to contain the transmission,"
लेख को पूरा पढ़ने के लिए कृपया नीचे दिए गए लिंक पर क्लिक करें:
ABC News: Israel is struggling with COVID-19, despite high vaccination rates. What lessons can Australia learn?
Commonwealth-funded places available for Nurse Immuniser course
There are limited places available for Registered Nurses (RNs) with one year of clinical experience to complete the Commonwealth-funded Nurse Immuniser short course free of charge (conditions apply).
The immunisation (Nurse immuniser) short course is based on the National Immunisation Education Framework for Health Professionals (2017) and has been accredited by the National body for health education Health Education Services Australia (HESA).
To find out more information on this course, please click on the links below. Please note some allocations have been exhausted.
The University of Melbourne: The immunisation (Nurse immuniser) short course
Benchmarque Group Immunisation Endorsement Pathway